Clin2
NCT07533292Likely a fitNot yet recruiting

Bacteriophage therapy for bone implant infections

OrthopedicImplant Infection

Treatments studied

Part of Bones, joints & muscles, Infections clinical trials.

This study tests a treatment using bacteriophages (special viruses that kill bacteria) for infections that happen around metal implants in bones. It aims to see if this approach can safely clear these hard-to-treat infections.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must not be allergic to bacteriophages or any part of the phage medicine.
  • You cannot be pregnant or breastfeeding during the study.
  • You must not be in another clinical trial during the study.
  • You must be able to receive treatment through an IV (intravenous line).
  • You must be willing and able to follow the study procedures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07461337Not yet recruiting· Phase 1/Phase 2
Bacteriophage therapy for stubborn joint infections

This trial tests a treatment using viruses that attack bacteria to fight a chronic infection in a joint replacement. It might help people whose joint infection has not cleared up with standard antibiotics or surgery.

Calgary
NCT06942624Not yet recruiting· Phase 1/Phase 2
Phage therapy for a long-term joint replacement infection

This trial tests a special treatment using viruses (called phages) that target and kill the bacteria causing a long-term joint replacement infection. It's designed for people who have tried many other treatments without success.

Winnipeg, Manitoba
NCT04650607Recruiting
Phage therapy safety check in serious infection patients

This study checks the safety of using phage therapy (viruses that target certain bacteria) in adults being treated for serious infections. If you meet the safety rules, your care team may enroll you to help confirm phage treatment is safe.

Lyon
NCT06605651Not yet recruiting· Phase 2
Phage therapy for knee or hip joint infections caused by staph bacteria

This trial tests a new treatment using viruses that attack bacteria (called phages) to fight infections in knee or hip replacements caused by Staphylococcus aureus. It may help people who still have the infection after a surgery to clean the joint, called DAIR.

NCT07619924Enrolling by invitation· Early Phase 1
Phage Cocktail for Hard-to-Treat Skin Infections

This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.

Xi'an, Shaanxi
NCT07698002Not yet recruiting· Phase 2/Phase 3
Phage therapy and antibiotics for joint infections

This study tests whether adding a treatment with special viruses (called phages) to standard antibiotic care can help clear a joint infection more effectively after surgery. The goal is to improve your chances of keeping the artificial hip or knee and avoid the need for more procedures.

Ottawa

Hear when a new Implant Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.